The U.S. and China restarted their trade talks, but signs are showing a comprehensive deal could be a long way off, if it happens at all.Marketsread more
The Swiss Federal Data Protection and Information Commissioner said on Tuesday it had not yet been contacted by Facebook about overseeing privacy protections for the Libra...Technologyread more
Stone, 66, a notorious Republican political operative who has described himself as a "dirty trickster," had previously been dressed down by the judge for his public remarks...Politicsread more
The Biden team's second quarter Federal Election Commission filing shows that the campaign wrote a check of just over $5,300 on June 28 to Sheehan Associates for "strategic...2020 Electionsread more
The speech comes as market participants are strongly anticipating a rate cut at the July 30-31 Federal Open Market Committee policy meeting.The Fedread more
Evans spoke Tuesday at CNBC's @Work Human Capital + Finance Conference in Chicago.The Fedread more
In prepared remarks for a congressional hearing, Facebook says Instagram and WhatsApp have had a greater chance to thrive after merging.Technologyread more
Spotify stock plunged over 1% on a report that Apple is spending money to create its own original podcasts.Technologyread more
American consumers are flexing their muscles, and that's helping to save the economy from even slower growth as it faces what could be a protracted trade war.Market Insiderread more
The Dow slipped from a record high set earlier in the day after President Trump cast doubt on the trade progress between China and the U.S.US Marketsread more
Oil prices turned lower on Tuesday, falling by about $2 a barrel as U.S. President Donald Trump said progress has been made with Iran, signaling tensions could ease in the...Energy Commoditiesread more
(Adds details, share movement, White House confirmation)
July 11 (Reuters) - The Trump administration has withdrawn a rule aimed at eliminating pharmaceutical drug rebates from its Medicare health plans, sending shares of Cigna Corp, the largest U.S. pharmacy benefit manager, up 9 percent in pre-market Thursday trading.
Politico https://www.politico.com/story/2019/07/11/white-house-drug-rebate-rule-1405884 reported the news on Thursday and the White House confirmed the decision to Reuters.
Shares of health insurers such as UnitedHealth Group Inc and drug distributors like McKesson Corp also rose after the report, as did those of drugstore chain CVS Health Corp and Walgreens Boots Alliance Inc.
In recent weeks, Politico and other publications reported that the White House and Health and Human Secretary Alex Azar disagreed over the rule, which was in the process of finalization.
The rule would have required pharmacy benefit managers and health insurers that provide drug benefits to pass on any drug manufacturer discounts or rebates to patients or obligated them to eliminate the rebates.
"Based on careful analysis and thorough consideration, the President has decided to withdraw the rebate rule," White House spokesman Judd Deere said in an emailed statement.
"The Trump administration is encouraged by continuing bipartisan conversations about legislation to reduce outrageous drug costs imposed on the American people, and President Trump will consider using any and all tools to ensure that prescription drug costs will continue to decline, he said.
(Reporting by Caroline Humer in New York and Ankur Banerjee in Bengaluru Editing by Saumyadeb Chakrabarty)